Kenvue, which has been under increased scrutiny recently after the Trump administration alleged a link between Tylenol and autism, is being acquired by Kimberly-Clark in a multibillion-dollar deal.According to a Monday press release, Kimberly-Clark will acquire all of the outstanding shares of Kenvu......